NCT03753243: Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 32 planned
- Started
- 3 Dec 2018
- Primary completion
- 3 Sep 2022
- Arms
- Intervention
- Results
- None posted
- 26 Nov 2018: Trial registered
- 3 Dec 2018: Trial started